Lion TCR - Crunchbase Company Profile & Funding

Q: Where is Lion TCR's headquarters?

Lion TCR is located in Singapore, Central Region, Singapore.

Q: Who invested in Lion TCR?

Lion TCR has 5 investors including CSPC NARD Capital And Guangzhou Industrial Investment Group.

Q: When was the last funding round for Lion TCR?

Lion TCR closed its last funding round on obfuscated from a Series B round.

Q: How much funding has Lion TCR raised to date?

Lion TCR has raised obfuscated.

Overview

Lion TCR

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Lion TCR

CB Rank

71001

Lion TCR is a clinical-stage biotechnology company.

Founded

obfuscation

Private

Series B

Singapore, Central Region, Singapore

11-50

liontcr.com/

Biotechnology

Health Care

Health Diagnostics

Therapeutics

Funding Rounds

Series B

OBF

obfuscation

Series A

OBF

obfuscation

Key People

Stephen Lim: COO
Lietao Li: Co-Founder, Chairman & CEO

Details

Legal Name

Lion TCR Pte. Ltd.

Operating Status

Active

Company Type

For Profit

Founders

Antonio Bertoletti, Lietao Li

About the Company

They are a clinical-stage biotechnology company that develops TCR-T cell therapy for cancers and life-threatening infectious diseases in Asia. For the past decade, they have accumulated expertise covering the entire product development process, ranging from basic research, T cell engineering and development, and preclinical/clinical

assessment. Led by industry and academic experts from their base in Singapore, they are dedicated to the commercialization and continued development of their immunotherapy products.

Phone Number

+65 6586 9633

Contact Email

info@liontcr.com

Predictions & Insights

Growth Insight

See this Growth Insight

Lion TCR is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Products & Services

LioCyx-M

An autologous T cell therapy engineered to express HBV-specific T cell receptors for targeting HBV-related hepatocellular carcinoma.

HBV-specific TCR Library

A collection of T cell receptors targeting HBV epitopes covering a broad range of HLA types prevalent in Asia for use in TCR-T cell therapies.

Research & Development

Lion TCR is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series B - Lion TCR	3	obfuscated obfuscation	Guangzhou Industrial Investment Group	Series B
obfuscated obfuscation	Series B - Lion TCR	3	obfuscated obfuscation	Guangzhou Industrial Investment Group	Series B
obfuscated obfuscation	Series B - Lion TCR	3	obfuscated obfuscation	Guangzhou Industrial Investment Group	Series B
obfuscated obfuscation	Series B - Lion TCR	3	obfuscated obfuscation	Guangzhou Industrial Investment Group	Series B
obfuscated obfuscation	Series B - Lion TCR	3	obfuscated obfuscation	Guangzhou Industrial Investment Group	Series B

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series B - Lion TCR	3	obfuscated obfuscation	Guangzhou Industrial Investment Group	Series B
obfuscated obfuscation	Series B - Lion TCR	3	obfuscated obfuscation	Guangzhou Industrial Investment Group	Series B
obfuscated obfuscation	Series B - Lion TCR	3	obfuscated obfuscation	Guangzhou Industrial Investment Group	Series B
obfuscated obfuscation	Series B - Lion TCR	3	obfuscated obfuscation	Guangzhou Industrial Investment Group	Series B
obfuscated obfuscation	Series B - Lion TCR	3	obfuscated obfuscation	Guangzhou Industrial Investment Group	Series B

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
CSPC NARD Capital	—	Series B - Lion TCR	Sun , Jumin
CSPC NARD Capital	—	Series B - Lion TCR	Sun , Jumin
CSPC NARD Capital	—	Series B - Lion TCR	Sun , Jumin
CSPC NARD Capital	—	Series B - Lion TCR	Sun , Jumin
CSPC NARD Capital	—	Series B - Lion TCR	Sun , Jumin